Pregnant and/or breastfeeding; patient must have a negative pregnancy test within hours of start of study treatment Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; patient must have a negative serum or urine pregnancy test within weeks of study entry Pregnant and/or breastfeeding; patient must have a negative serum or urine pregnancy test within hours of study entry Pregnant and/or breastfeeding; patient must have a negative pregnancy test within days of the start of treatment Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant or breastfeeding; a negative serum pregnancy test is required no more than days before study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative urine pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have two negative pregnancy tests; the first test should be performed within - days of study entry, and the second test within hours prior to prescribing pomalidomide Pregnant and/or breastfeeding; patient must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of signing consent Pregnant and/or breastfeeding; women of childbearing potential must have a negative serum or urine pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative serum or urine pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within hours of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative serum pregnancy test within days of study entry Pregnant and/or breastfeeding; patient must have a negative serum or urine pregnancy test within hours of study entry Pregnant or nursing; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; patient must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within days of study entry. Pregnant or breastfeeding; a negative serum pregnancy test is required no more than days before study entry Pregnant and/or breastfeeding; premenopausal women must have a negative serum or urine pregnancy test within days of study entry Pregnant and/or breastfeeding; premenopausal women must have a negative serum or urine pregnancy test within days of study entry (Arm B) Pregnant and/or breastfeeding; patient must have a negative pregnancy test within days of start of study treatment Pregnant or breastfeeding; a negative serum pregnancy test is required no more than days before study entry Pregnant and/or breastfeeding; patients of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within days of study entry Pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within days of study entry if premenopausal Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within hours of study entry Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within days of study entry and again within hours prior to first treatment. Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within days of first dose of vaccine. Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Female patients who are pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within days of study entry Pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within days of study entry Pregnant or breastfeeding, or intending to become pregnant during the study; women of childbearing potential must have a negative serum pregnancy test result within days prior to initiation of study treatment Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of first dose of vaccine Pregnant and/or breastfeeding; patient must have a negative urine pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative serum or urine pregnancy test within days of study entry Pregnant and/or breastfeeding; patients of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; patient must have a negative urine pregnancy test within days of study entry Pregnant and/or breastfeeding; patient must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; patients that are of childbearing age must have a negative pregnancy test at screening and agree on using contraception during the duration of the study Pregnant and/or breastfeeding: patient must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; patient must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of initiation of treatment Pregnant or breastfeeding patients; women of childbearing potential must have a documented negative pregnancy test a maximum of days before start of treatment Pregnant and/or breastfeeding; premenopausal women must have a negative serum or urine pregnancy test within days of study entry Patient must not be pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within days of study entry Pregnant or breastfeeding; a negative pregnancy test is required within days of randomization for all women of childbearing potential Pregnant and/or breastfeeding; patient must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; patient must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding women; women of childbearing potential must have a negative serum pregnancy test within days of study entry Patient must not be pregnant and/or breastfeeding; patient must have a negative urine pregnancy test within seven days of study entry Pregnant and/or breastfeeding; patient must have a negative serum or urine pregnancy test within hours of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; patient must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; patient must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within days of study entry Pregnant and/or breastfeeding; female patients must have a negative urine pregnancy test within days of study entry Breastfeeding or pregnant; serum pregnancy test will be conducted